Complement component C3 mediates inflammatory injury following focal cerebral ischemia

J. Mocco, William J. Mack, Andrew F. Ducruet, Sergei A. Sosunov, Michael E. Sughrue, Benjamin G. Hassid, M. Nathan Nair, Ilya Laufer, Ricardo J Komotar, M. Claire H Holland, David J. Pinsky, E. Sander Connolly

Research output: Contribution to journalArticle

136 Citations (Scopus)

Abstract

The complement cascade has been implicated in ischemia/reperfusion injury, and recent studies have shown that complement inhibition is a promising treatment option for acute stroke. The development of clinically useful therapies has been hindered, however, by insufficient understanding of which complement subcomponents contribute to post-ischemic injury. To address this issue, we subjected mice deficient in selected complement proteins (C1q, C3, C5) to transient focal cerebral ischemia. Of the strains investigated, only C3 mice were protected, as demonstrated by 34% reductions in both infarct volume (P<0.01) and neurological deficit score (P<0.05). C3-deficient mice also manifested decreased granulocyte infiltration (P<0.02) and reduced oxidative stress (P<0.05). Finally, administration of a C3a-receptor antagonist resulted in commensurate neurological improvement and stroke volume reduction (P<0.05). Together, these results establish C3 activation as the key constituent in complement-related inflammatory tissue injury following stroke and suggest a C3a anaphylatoxin-mediated mechanism.

Original languageEnglish
Pages (from-to)209-217
Number of pages9
JournalCirculation Research
Volume99
Issue number2
DOIs
StatePublished - Jul 1 2006
Externally publishedYes

Fingerprint

Complement C3
Brain Ischemia
Wounds and Injuries
Stroke
Complement C1q
Anaphylatoxins
Transient Ischemic Attack
Reperfusion Injury
Granulocytes
Stroke Volume
Complement System Proteins
Oxidative Stress
Therapeutics

Keywords

  • C3
  • Complement
  • Neuroprotection

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Mocco, J., Mack, W. J., Ducruet, A. F., Sosunov, S. A., Sughrue, M. E., Hassid, B. G., ... Connolly, E. S. (2006). Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circulation Research, 99(2), 209-217. https://doi.org/10.1161/01.RES.0000232544.90675.42

Complement component C3 mediates inflammatory injury following focal cerebral ischemia. / Mocco, J.; Mack, William J.; Ducruet, Andrew F.; Sosunov, Sergei A.; Sughrue, Michael E.; Hassid, Benjamin G.; Nair, M. Nathan; Laufer, Ilya; Komotar, Ricardo J; Holland, M. Claire H; Pinsky, David J.; Connolly, E. Sander.

In: Circulation Research, Vol. 99, No. 2, 01.07.2006, p. 209-217.

Research output: Contribution to journalArticle

Mocco, J, Mack, WJ, Ducruet, AF, Sosunov, SA, Sughrue, ME, Hassid, BG, Nair, MN, Laufer, I, Komotar, RJ, Holland, MCH, Pinsky, DJ & Connolly, ES 2006, 'Complement component C3 mediates inflammatory injury following focal cerebral ischemia', Circulation Research, vol. 99, no. 2, pp. 209-217. https://doi.org/10.1161/01.RES.0000232544.90675.42
Mocco, J. ; Mack, William J. ; Ducruet, Andrew F. ; Sosunov, Sergei A. ; Sughrue, Michael E. ; Hassid, Benjamin G. ; Nair, M. Nathan ; Laufer, Ilya ; Komotar, Ricardo J ; Holland, M. Claire H ; Pinsky, David J. ; Connolly, E. Sander. / Complement component C3 mediates inflammatory injury following focal cerebral ischemia. In: Circulation Research. 2006 ; Vol. 99, No. 2. pp. 209-217.
@article{926ef1bb69254663b298f811b347a531,
title = "Complement component C3 mediates inflammatory injury following focal cerebral ischemia",
abstract = "The complement cascade has been implicated in ischemia/reperfusion injury, and recent studies have shown that complement inhibition is a promising treatment option for acute stroke. The development of clinically useful therapies has been hindered, however, by insufficient understanding of which complement subcomponents contribute to post-ischemic injury. To address this issue, we subjected mice deficient in selected complement proteins (C1q, C3, C5) to transient focal cerebral ischemia. Of the strains investigated, only C3 mice were protected, as demonstrated by 34{\%} reductions in both infarct volume (P<0.01) and neurological deficit score (P<0.05). C3-deficient mice also manifested decreased granulocyte infiltration (P<0.02) and reduced oxidative stress (P<0.05). Finally, administration of a C3a-receptor antagonist resulted in commensurate neurological improvement and stroke volume reduction (P<0.05). Together, these results establish C3 activation as the key constituent in complement-related inflammatory tissue injury following stroke and suggest a C3a anaphylatoxin-mediated mechanism.",
keywords = "C3, Complement, Neuroprotection",
author = "J. Mocco and Mack, {William J.} and Ducruet, {Andrew F.} and Sosunov, {Sergei A.} and Sughrue, {Michael E.} and Hassid, {Benjamin G.} and Nair, {M. Nathan} and Ilya Laufer and Komotar, {Ricardo J} and Holland, {M. Claire H} and Pinsky, {David J.} and Connolly, {E. Sander}",
year = "2006",
month = "7",
day = "1",
doi = "10.1161/01.RES.0000232544.90675.42",
language = "English",
volume = "99",
pages = "209--217",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Complement component C3 mediates inflammatory injury following focal cerebral ischemia

AU - Mocco, J.

AU - Mack, William J.

AU - Ducruet, Andrew F.

AU - Sosunov, Sergei A.

AU - Sughrue, Michael E.

AU - Hassid, Benjamin G.

AU - Nair, M. Nathan

AU - Laufer, Ilya

AU - Komotar, Ricardo J

AU - Holland, M. Claire H

AU - Pinsky, David J.

AU - Connolly, E. Sander

PY - 2006/7/1

Y1 - 2006/7/1

N2 - The complement cascade has been implicated in ischemia/reperfusion injury, and recent studies have shown that complement inhibition is a promising treatment option for acute stroke. The development of clinically useful therapies has been hindered, however, by insufficient understanding of which complement subcomponents contribute to post-ischemic injury. To address this issue, we subjected mice deficient in selected complement proteins (C1q, C3, C5) to transient focal cerebral ischemia. Of the strains investigated, only C3 mice were protected, as demonstrated by 34% reductions in both infarct volume (P<0.01) and neurological deficit score (P<0.05). C3-deficient mice also manifested decreased granulocyte infiltration (P<0.02) and reduced oxidative stress (P<0.05). Finally, administration of a C3a-receptor antagonist resulted in commensurate neurological improvement and stroke volume reduction (P<0.05). Together, these results establish C3 activation as the key constituent in complement-related inflammatory tissue injury following stroke and suggest a C3a anaphylatoxin-mediated mechanism.

AB - The complement cascade has been implicated in ischemia/reperfusion injury, and recent studies have shown that complement inhibition is a promising treatment option for acute stroke. The development of clinically useful therapies has been hindered, however, by insufficient understanding of which complement subcomponents contribute to post-ischemic injury. To address this issue, we subjected mice deficient in selected complement proteins (C1q, C3, C5) to transient focal cerebral ischemia. Of the strains investigated, only C3 mice were protected, as demonstrated by 34% reductions in both infarct volume (P<0.01) and neurological deficit score (P<0.05). C3-deficient mice also manifested decreased granulocyte infiltration (P<0.02) and reduced oxidative stress (P<0.05). Finally, administration of a C3a-receptor antagonist resulted in commensurate neurological improvement and stroke volume reduction (P<0.05). Together, these results establish C3 activation as the key constituent in complement-related inflammatory tissue injury following stroke and suggest a C3a anaphylatoxin-mediated mechanism.

KW - C3

KW - Complement

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=33747598070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747598070&partnerID=8YFLogxK

U2 - 10.1161/01.RES.0000232544.90675.42

DO - 10.1161/01.RES.0000232544.90675.42

M3 - Article

C2 - 16778128

AN - SCOPUS:33747598070

VL - 99

SP - 209

EP - 217

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 2

ER -